RED BLOOD CELLS
The challenge with blood supply
State of the industry
The global blood supply is under strain, with a stark shortage rooted in an insufficient number of donors and the growing needs of patients suffering from conditions such as sickle cell anemia. This shortage is not just a number issue; it's about real lives needing vital treatments that depend on steady access to safe blood. The situation underscores the urgent need for methods to mass-produce red blood cells, offering a stable and safe alternative to traditional blood donations. Such advancements are required to revolutionize treatment options, making essential care more accessible to those in dire need.